SharesGrow.com Intrinsic Value of S&P & Nasdaq Contact Us

हिन्दी

← Back to all stocks

Genetron Holdings Limited GTH NASDAQ

NASDAQ Global Market • Healthcare • Medical - Diagnostics & Research • CN • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

Genetron Holdings Limited (GTH) is a Medical - Diagnostics & Research company in the Healthcare sector, currently trading at $4.03. It has a SharesGrow Score of 46/100, indicating a mixed investment profile with 1 out of 7 criteria passed.

Financials: revenue is $651M, +26.3%/yr average growth. Net income is $884M (loss), growing at -61.5%/yr. Net profit margin is -135.8% (negative). Gross margin is 43.2% (-1.6 pp trend).

Balance sheet: total debt is $159M against $546M equity (Debt-to-Equity (D/E) ratio 0.29, conservative). Current ratio is 1.82 (strong liquidity). Debt-to-assets is 16.3%. Total assets: $975M.

Analyst outlook: 2 / 2 analysts rate GTH as buy (100%) — strong consensus.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 58/100 (Partial), Past 0/100 (Fail), Health 67/100 (Partial), Moat 47/100 (Partial), Future 100/100 (Pass), Income 10/100 (Fail).

GTH SharesGrow Score Overview

56/100

SharesGrow Score

Above average fundamentals

View full scorecard →

VALUE 0/100

Valuation — P/E, PEG, Forward PEG

GROWTH 58/100

Financials — average growth

PAST 0/100

strong — trend

HEALTH 67/100

Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is

MOAT 47/100

Gross margin is + market cap

FUTURE 100/100

Analyst outlook — as buy

INCOME 10/100

Net profit margin is

Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — GTH

No analyst coverage available for this stock.

GTH: +26.3%/yr revenue is, -61.5%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.

View details →

No analyst coverage available for this stock.

Balance sheet GTH: Debt-to-Equity (D/E) ratio 0.29 (conservative), Current ratio is 1.82 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.

View details →

GTH: Gross margin is 43.2% (-1.6 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 47/100. ≥ 70 = Pass.

View details →

Analyst outlook: 2 / 2 analysts rate GTH as buy (100%). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.

View details →

GTH: Net profit margin is -135.8%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.

View details →

Stock Chart & Stats

Market Data

52-Week Range2.0802-4.05

Volume412.6K

Avg Volume (30D)51.86K

Market Cap$127.29M

Beta (1Y)0.50

Share Statistics

EPS (TTM)-9.53

Shares Outstanding$92.8M

IPO Date2020-06-15

Employees993

CEOSizhen Wang

Financial Highlights & Ratios

Revenue (TTM)$650.71M

Gross Profit$281.43M

EBITDA$-651.24M

Net Income$-883.89M

Operating Income$-631.62M

Total Cash$333.69M

Total Debt$158.57M

Net Debt$-17.7M

Total Assets$975.33M

Price / Earnings (P/E)-0.4

Price / Sales (P/S)0.2

Analyst Forecast

Rating ConsensusBuy

Analysts Covering2

Buy 100% Hold 0% Sell 0%

Company Info

CountryCN

ExchangeNASDAQ Global Market

CurrencyUSD

ISINUS37186H2094

Price Chart

GTH

Genetron Holdings Limited ↗ · NASDAQ Global Market

Healthcare • Medical - Diagnostics & Research

2.08 52WK RANGE 4.05

People Also View

Sotera Health Company

Olink Holding AB (publ)

Castle Biosciences, Inc.

Aclaris Therapeutics, Inc.

Prenetics Global Limited

FONAR Corporation

Contact Us

🎓

SharesGrow Academy

Learn how to calculate Intrinsic Value and find undervalued stocks.

Weekly live sessions

📧 [email protected]

📞 +65 8912 8000

Send us a message